>
Company >
History
-
2023
- 06Concluded an agreement for the consignment sales contract of cytokine with Dr.Bio
-
2021
- 09Concluded an agreement for the joint research for anti-cancer immune cell therapy 'CAR-M' with Oncoinsight
-
2020
- 07Obtainment of the patent registrations for the manufacturing technology of anticancer / autoimmune disease dendritic cell therapy products both in Europe and China
-
2017
- 07IND approval for the Phase I/II clinical trial on CreaVax-BC
-
2015
- 07CreaVax-BC, Orphan drug designation
-
2014
- 03IND approval for the Phase III clinical trial on CreaVax- HCC
-
2013
- 05IND approval for the Phase IIa clinical trial on CreaVax-RA
-
2012
- 11Commencement of antigens/cytokines business
- 03Completion of the construction of manufacturing plant in Chuncheon
-
2011
- 03Changed the company name to JW CreaGene Co., Ltd.
-
2010
- 06IND approval for the Phase I clinical trial on CreaVax-RA
- 03IND approval for the Phase II clinical trial on CreaVax- HCC
-
2009
- 05Merged by JW Shinyak as a subsidiary company (JW of Companies)
- 02Establishment of overseas corporation of CreaGene in Japan and commencement of overseas clinical test for CreaVax-HCC at the Ehime University Hospital in Japan
-
2008
- 09IND approval for the Phases I/IIa clinical trial n CreaVax-HCC
-
2007
- 05approval by KFDA/ Approval of KGMP
-
2006
- 12Transfer of the headquarters to Seongnam, received the outstanding award in the "Health Industry Technology Fair" by the Korea Health Industry Development Institute
- 06Certification as technology innovation type small and medium company (INNO-BIZ) by the Small and Medium Business Administration
- 04Certification for confirmation as a venture company by the Small and Medium Business Administration
- Certification for transparent management by the Korea Technology Finance Corporation
-
2005
- 05Merged as the subsidiary company of Three Seven Co., Ltd.
-
2000
- Establishment and certification of the subsidiary Research Center
-
1999
- Changed the company name to CreaGene Co., Ltd.
-
1998
- Incorporation of Artwell Biotech Co., Ltd.
